Literature DB >> 12630436

Exposure to benzene and risk of leukemia among shoe factory workers.

Adele Seniori Costantini1, Margaret Quinn, Dario Consonni, Marco Zappa.   

Abstract

OBJECTIVES: The study attempted to add years of follow-up to an earlier study describing excess leukemia among workers exposed to benzene-based glues in a shoe-factory and to conduct a quantitative exposure assessment of the exposure to benzene and the risk of leukemia.
METHODS: The cohort comprised 1687 persons with complete work histories, at work on 1 January 1950, and followed through 31 December 1999. For each subject, time-specific cumulative exposure (ppm-years) was calculated as the sum of the products of job-specific concentrations of benzene (ppm) and the duration (years) for each job. Standardized mortality ratios (SMR) were estimated using national and regional rates specific for gender, age, and period.
RESULTS: The cumulative exposure ranged from 0 to >500 ppm-years. The SMR values for all hematolymphopoietic malignancies and leukemia for the men and women combined were elevated in all but the lowest exposure category. Leukemia risk was significantly elevated in the highest exposure category and the most evident among the men. The SMR values for the men were 1.4 [95% confidence interval (95% CI) 0.2-5.0], 3.7 (95% CI 0.1-20.6), 3.0 (95% CI 0.4-10.9), and 7.0 (95% CI 1.9-18.0) for benzene, the cumulative exposure equaling <40, 40-99, 100-199, and >200 ppm-years, respectively.
CONCLUSIONS: The results indicate that leukemia mortality is associated with exposure to benzene in this factory and that the risk increases with increasing cumulative exposure. The relevance of these findings for estimating risk at much lower levels is limited because of the small study size.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12630436     DOI: 10.5271/sjweh.704

Source DB:  PubMed          Journal:  Scand J Work Environ Health        ISSN: 0355-3140            Impact factor:   5.024


  8 in total

1.  Benzene Exposure Response and Risk of Myeloid Neoplasms in Chinese Workers: A Multicenter Case-Cohort Study.

Authors:  Martha S Linet; Ethel S Gilbert; Roel Vermeulen; Graça M Dores; Song-Nian Yin; Lutzen Portengen; Richard B Hayes; Bu-Tian Ji; Qing Lan; Gui-Lan Li; Nathaniel Rothman
Journal:  J Natl Cancer Inst       Date:  2019-05-01       Impact factor: 13.506

2.  Temozolomide-induced myelodysplasia.

Authors:  Ethan A Natelson; David Pyatt
Journal:  Adv Hematol       Date:  2010-03-04

3.  Flexible meta-regression to assess the shape of the benzene-leukemia exposure-response curve.

Authors:  Jelle Vlaanderen; Lützen Portengen; Nathaniel Rothman; Qing Lan; Hans Kromhout; Roel Vermeulen
Journal:  Environ Health Perspect       Date:  2009-11-18       Impact factor: 9.031

Review 4.  Exposure to benzene at work and the risk of leukemia: a systematic review and meta-analysis.

Authors:  Abdul Khalade; Maritta S Jaakkola; Eero Pukkala; Jouni J K Jaakkola
Journal:  Environ Health       Date:  2010-06-28       Impact factor: 5.984

Review 5.  Etiology of Acute Leukemia: A Review.

Authors:  Cameron K Tebbi
Journal:  Cancers (Basel)       Date:  2021-05-08       Impact factor: 6.639

6.  Risk perception and occupational accidents: a study of gas station workers in southern Brazil.

Authors:  Marta Regina Cezar-Vaz; Laurelize Pereira Rocha; Clarice Alves Bonow; Mara Regina Santos da Silva; Joana Cezar Vaz; Letícia Silveira Cardoso
Journal:  Int J Environ Res Public Health       Date:  2012-07-03       Impact factor: 3.390

7.  Leukaemia incidence among workers in the shoe and boot manufacturing industry: a case-control study.

Authors:  Steven P Forand
Journal:  Environ Health       Date:  2004-08-30       Impact factor: 5.984

8.  Evaluation of occupational exposure of shoe makers to benzene and toluene compounds in shoe manufacturing workshops in East tehran.

Authors:  Mansour R Azari; Vajihe Hosseini; Mohammad Javad Jafari; Hamid Soori; Parisa Asadi; Seid Mohammad Ali Mousavion
Journal:  Tanaffos       Date:  2012
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.